Harnessing the power of IFN for therapeutic approaches to COVID-19
Journal of Virology · 2024
DOI: 10.1128/jvi.01204-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Virology, 2024. Verfasst von Elise G Viox und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Interferons. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: William I. H. and Lula E. Pitts Foundation (William I. H. & Lula E. Pitts Foundation), HHS | National Institutes of Health (NIH), NIH HHS.
Abstract (Originalsprache)
Interferons (IFNs) are essential for defense against viral infections but also drive recruitment of inflammatory cells to sites of infection, a key feature of severe COVID-19. Here, we explore the complexity of the IFN response in COVID-19, examine the effects of manipulating IFN on SARS-CoV-2 viral replication and pathogenesis, and highlight pre-clinical and clinical studies evaluating the therapeutic efficacy of IFN in limiting COVID-19 severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.
- Emory NPRC Genomics Core Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.
- Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
ORCID-Profile: Elise G Viox, Gideon Schreiber, Mirko Paiardini
Förderung
- William I. H. and Lula E. Pitts Foundation (William I. H. & Lula E. Pitts Foundation)
- HHS | National Institutes of Health (NIH)
- NIH HHS
- Emory University (EU)
- Fast Grants (Fast Grants from Emergent Ventures)
Zitieren
APA
Viox, E. G., Bosinger, S. E., Douek, D. C., Schreiber, G., & Paiardini, M. (2024). Harnessing the power of IFN for therapeutic approaches to COVID-19. Journal of Virology. https://doi.org/10.1128/jvi.01204-23
Vancouver
Viox EG, Bosinger SE, Douek DC, Schreiber G, Paiardini M. Harnessing the power of IFN for therapeutic approaches to COVID-19. Journal of Virology. 2024. doi:10.1128/jvi.01204-23
BibTeX
@article{Viox2024,
author = {Viox, Elise G and Bosinger, Steven E and Douek, Daniel C and Schreiber, Gideon and Paiardini, Mirko},
title = {Harnessing the power of IFN for therapeutic approaches to COVID-19},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01204-23}
}
EUVIMED